Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $21 at Piper Sandler
Tweet
Share
E-mailGet Alerts BHVN Hot Sheet
Price: $14.39 -0.69%
Rating Summary:
17 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
17 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Piper Sandler analyst Christopher J. Raymond lowered the price target on Biohaven Pharmaceutical Holding (NYSE: BHVN) to $21.00 (from $23.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Biohaven Pharma (BHVN) PT Raised to $23 at RBC Capital
- Riskified Ltd. (RSKD) PT Raised to $5.50 at Goldman Sachs
- Nomura/Instinet Upgrades Seiko Group Corp (8050:JP) to Buy
Create E-mail Alert Related Categories
Analyst PT Change, Hot CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
